- Home
- BDRX vs AEMD Comparison
BDRX vs AEMD Comparison
Compare BDRX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | AEMD |
|---|---|---|
| Founded | 2000 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 2.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BDRX | AEMD |
|---|---|---|
| Price | $1.21 | $2.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $287.50 |
| AVG Volume (30 Days) | ★ 517.1K | 61.5K |
| Earning Date | 09-12-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $2.08 |
| 52 Week High | $92.00 | $60.20 |
Technical Indicators
Market Signals| Indicator | BDRX | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.35 | 35.37 |
| Support Level | $1.22 | $2.08 |
| Resistance Level | $1.38 | $2.32 |
| Average True Range (ATR) | 0.14 | 0.23 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 0.93 | 1.45 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.